Psilocybin

A new research center funded by private donors will study possible psilocybin therapies at Johns Hopkins Medicine.

The findings come amid what is known as the "psychedelic renaissance."

Psilocybin mushrooms, often called magic mushrooms or shrooms, might soon be partially legal, or at least decriminalized, in several states. Here's how to trip safely.

"This is what happens when a small team of dedicated and passionate people unite under a single idea to create change," said Kevin Matthews, the director of the Decriminalize Denver.

The researchers hope their study could help people with mental disorders such as schizophrenia.

Psilocybin is increasingly being recognized by scientists as potentially effective treatments for a number of psychological disorders, such as addiction and depression.

Findings suggest that psychedelics could be used to treat a host of mood and anxiety disorders, such as depression, anxiety, addiction and post-traumatic stress disorder.

Results could one day lead to novel treatments or therapies for reducing domestic violence, the lead author said.

Magic mushrooms' hallucinogenic effects might keep insects away, but it doesn't stop humans.

"Psilocybin may produce sustained changes in outlook and political perspective."

Mayoral candidate says the fungi saved him from heroin.

Brain scans revealed that psilocybin could be more effective than antidepressants.

The study could pave the way for easier production of the psychedelic psilocybin.

Only 0.2 percent of people who tried shrooms within the last year wound up in the emergency room, according to the Global Drug Survey.

The criteria​ for banning a drug exist to make congressional and DEA determinations look scientific, even when they are not.

The drug could be used to help treat anxiety and depression in the future.

A letter published in the Lancet Psychiatry Journal has claimed that psychedelic drugs are safer than currently thought.

Scientists and scholars discussed experiments with psychedelics drugs to treat anxiety, depression, addiction and other issues at a recent conference in New York City.

Participants at Johns Hopkins reported an 80 percent abstinence from cigarettes following the psilocybin study